Cargando…

Plasma cytokeratin‐18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib

BACKGROUND: No biomarkers for the early detection of gastrointestinal (GI) toxicosis secondary to antineoplastic treatment are recognized in veterinary medicine. Toceranib causes GI toxicosis in dogs. HYPOTHESIS/OBJECTIVE: To assess if changes in plasma cytokeratin 18 (CK18) concentration, measured...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovac, Rachel L., Ballash, Gregory, Fenger, Joelle, London, Cheryl, Warry, Emma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2018
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271317/ https://www.ncbi.nlm.nih.gov/pubmed/30353992 http://dx.doi.org/10.1111/jvim.15326

Ejemplares similares

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs
por: Berger, Erika P., et al.
Publicado: (2018)

Effects of Toceranib Phosphate on Systolic Blood Pressure and Proteinuria in Dogs
por: Tjostheim, S.S., et al.
Publicado: (2016)

Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs
por: Heaton, Caitlin M., et al.
Publicado: (2020)

Effects of Toceranib Phosphate on the Hypothalamic‐Pituitary‐Thyroid Axis in Tumor‐Bearing Dogs
por: Hume, K.R., et al.
Publicado: (2017)

Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs
por: Yamazaki, Hiroki, et al.
Publicado: (2020)

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
por: Weishaar, K.M., et al.
Publicado: (2017)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015)

Toxicosis with grapes or raisins causing acute kidney injury and neurological signs in dogs
por: Schweighauser, Ariane, et al.
Publicado: (2020)

Outcomes of nonsteroidal anti‐inflammatory drug toxicosis treated with therapeutic plasma exchange in 62 dogs
por: Butty, Emmanuelle M., et al.
Publicado: (2022)

Plasma Cytokeratin 18 and fecal Alpha‐1 Antitrypsin concentrations in dogs with osteosarcoma receiving carboplatin chemotherapy
por: Taikowski, Kathryn, et al.
Publicado: (2020)

Outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
por: Chalifoux, Nolan V., et al.
Publicado: (2022)

MicroRNA expression in the cerebrospinal fluid of dogs with and without cervical spondylomyelopathy
por: Vansteenkiste, Daniella P., et al.
Publicado: (2019)

Assessment of eosinophils in gastrointestinal inflammatory disease of dogs
por: Bastan, Idil, et al.
Publicado: (2018)

Usefulness of noninvasive shear wave elastography for the assessment of hepatic fibrosis in dogs with hepatic disease
por: Tamura, Masahiro, et al.
Publicado: (2019)

Noninvasive Assessment of Neuromuscular Disease in Dogs: Use of the 6‐minute Walk Test to Assess Submaximal Exercise Tolerance in Dogs with Centronuclear Myopathy
por: Cerda‐Gonzalez, S., et al.
Publicado: (2016)

Use of video capsule endoscopy to identify gastrointestinal lesions in dogs with microcytosis or gastrointestinal hemorrhage
por: Mabry, Kasey, et al.
Publicado: (2019)

Evaluation of a 3‐dimensional ultrasound device for noninvasive measurement of urinary bladder volume in dogs
por: DiFazio, Matthew R., et al.
Publicado: (2020)

Effects of desmopressin acetate administration in healthy dogs receiving prednisolone
por: Galati, Pamela, et al.
Publicado: (2021)

Repetitive transcranial magnetic stimulation in drug‐resistant idiopathic epilepsy of dogs: A noninvasive neurostimulation technique
por: Charalambous, Marios, et al.
Publicado: (2020)

Effect of Laparoscopic‐assisted Gastropexy on Gastrointestinal Transit Time in Dogs
por: Balsa, I.M., et al.
Publicado: (2017)

Complications of Percutaneous Endoscopic Gastrostomy in Dogs and Cats Receiving Corticosteroid Treatment
por: Aguiar, J., et al.
Publicado: (2016)

Neutropenia in dogs receiving vincristine for treatment of presumptive immune‐mediated thrombocytopenia
por: LaQuaglia, Kathryn A., et al.
Publicado: (2021)

The effect of combined carprofen and omeprazole administration on gastrointestinal permeability and inflammation in dogs
por: Jones, Susan M., et al.
Publicado: (2020)

Evaluation of resting cortisol concentration testing in dogs with chronic gastrointestinal signs
por: Gallego, Ana Fernandez, et al.
Publicado: (2022)

Diagnostic evaluation of urea nitrogen/creatinine ratio in dogs with gastrointestinal bleeding
por: Stiller, Jenny, et al.
Publicado: (2021)

Gastrointestinal angiodysplasias diagnosed using video capsule endoscopy in 15 dogs
por: Defarges, Alice, et al.
Publicado: (2023)

Heparin‐Induced Hyperkalemia in a Dog Receiving Continuous Renal Replacement Treatment
por: Geesaman, B., et al.
Publicado: (2015)

Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin
por: Hallman, Briana E., et al.
Publicado: (2019)

Clinical features and outcomes in 38 dogs with cholelithiasis receiving conservative or surgical management
por: Allan, Frederik, et al.
Publicado: (2021)

Bacterial urinary tract infection and subclinical bacteriuria in dogs receiving antineoplastic chemotherapy
por: Harrer, Julia, et al.
Publicado: (2022)

Prevalence of gastrointestinal lesions in dogs chronically treated with nonsteroidal anti‐inflammatory drugs
por: Mabry, Kasey, et al.
Publicado: (2021)

Effectiveness of 2‐dimensional shear wave elastography for noninvasive and reliable estimation of right atrial pressure in dogs with induced volume overload
por: Tamura, Masahiro, et al.
Publicado: (2023)

Prevalence and characterization of hypoadrenocorticism in dogs with signs of chronic gastrointestinal disease: A multicenter study
por: Hauck, Christina, et al.
Publicado: (2020)

Clinical effect of probiotics in prevention or treatment of gastrointestinal disease in dogs: A systematic review
por: Jensen, Anders P., et al.
Publicado: (2019)

Frequency of signs of chronic gastrointestinal disease in dogs after an episode of acute hemorrhagic diarrhea
por: Skotnitzki, Elisabeth, et al.
Publicado: (2021)

Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin
por: Henry, C.J., et al.
Publicado: (2017)

Blood Transfusions in Dogs and Cats Receiving Hemodialysis: 230 Cases (June 1997–September 2012)
por: Langston, C., et al.
Publicado: (2017)

Multicenter retrospective evaluation of ileocecocolic perforations associated with diagnostic lower gastrointestinal endoscopy in dogs and cats
por: Woolhead, Vanessa L., et al.
Publicado: (2020)

Association of fecal and serum microRNA profiles with gastrointestinal cancer and chronic inflammatory enteropathy in dogs
por: Lyngby, Janne G., et al.
Publicado: (2022)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
por: Ames, Marisa K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c7h2ogakl5fj5go6lfmnju3tuv